Artificial intelligence (AI)-based models can potentially reduce workload and assist general pathologists in reaching genitourinary pathologists’ performance. A recent large-scale competition to develop generalizable AI models for prostate cancer detection and grading has shown success; implementation of such models positions them beyond hype and as today’s reality.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
LeCun, Y., Bengio, Y. & Hinton, G. Deep learning. Nature 521, 436–444 (2015).
Litjens, G. et al. A survey on deep learning in medical image analysis. Med. Image Anal. 42, 60–88 (2017).
Bulten, W. et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nat. Med. 28, 154–163 (2022).
Campanella, G. et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat. Med. 25, 1301–1309 (2019).
Goldenberg, S. L., Nir, G. & Salcudean, S. E. A new era: artificial intelligence and machine learning in prostate cancer. Nat. Rev. Urol. 16, 391–403 (2019).
Nagendran, M. et al. Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies. BMJ 368, m689 (2020).
Bejnordi, B. E. et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA 318, 2199–2210 (2017).
Williams, B. J., Bottoms, D., Clark, D. & Treanor, D. Future-proofing pathology part 2: building a business case for digital pathology. J. Clin. Pathol. 72, 198–205 (2019).
Paige. Paige receives first ever FDA approval for AI product in digital pathology. Paige https://www.paige.ai/news/news-press-release1/ (2021).
Kather, J. N. et al. Pan-cancer image-based detection of clinically actionable genetic alterations. Nat. Cancer 1, 789–799 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Bashashati, A., Goldenberg, S.L. AI for prostate cancer diagnosis — hype or today’s reality?. Nat Rev Urol 19, 261–262 (2022). https://doi.org/10.1038/s41585-022-00583-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-022-00583-4
This article is cited by
-
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment
Nature Reviews Urology (2024)
-
Machine learning applications in detection and diagnosis of urology cancers: a systematic literature review
Neural Computing and Applications (2024)